CATALYST PHARMACEUTICALS, INC. — Net Income by Fiscal Year
24 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/48ef4359-8fb0-4e4f-8963-0605797084c7/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $214.3M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-071525 |
| FY 2024 | $163.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-027714 |
| FY 2023 | $71.4M | 2023-01-01 – 2023-12-31 | evidence 0001193125-24-050908 |
| FY 2022 | $83.1M | 2022-01-01 – 2022-12-31 | evidence 0001193125-23-071299 |
| FY 2021 | $39.5M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-077228 |
| FY 2020 | $75.0M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-081545 |
| FY 2019 | $31.9M | 2019-01-01 – 2019-12-31 | evidence 0001193125-22-077228 |
| FY 2018 | $-34.0M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-078253 |
| FY 2017 | $-18.4M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-082292 |
| FY 2016 | $-18.1M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-083667 |
| FY 2015 | $-20.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-505167 |
| FY 2014 | $-15.5M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-091323 |
| FY 2013 | $-58.1M | 2002-01-05 – 2014-03-31 | evidence 0001193125-14-201244 |
| FY 2012 | $-43.9M | 2002-01-04 – 2013-03-31 | evidence 0001193125-13-222410 |
| FY 2011 | $-39.2M | 2002-01-04 – 2012-03-31 | evidence 0001193125-12-234618 |
| FY 2010 | $-4.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-143728 |
| FY 2009 | $-7.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-143728 |
| FY 2008 | $-10.6M | 2008-01-01 – 2008-12-31 | evidence 0001193125-12-143728 |
| FY 2007 | $-4.1M | 2007-01-01 – 2007-12-31 | evidence 0001193125-12-143728 |
| FY 2006 | $-2.7M | 2006-01-01 – 2006-12-31 | evidence 0001193125-12-143728 |
| FY 2005 | $-1.8M | 2005-01-01 – 2005-12-31 | evidence 0001193125-12-143728 |
| FY 2004 | $-539.8k | 2004-01-01 – 2004-12-31 | evidence 0001193125-12-143728 |
| FY 2003 | $-428.6k | 2003-01-01 – 2003-12-31 | evidence 0001193125-12-143728 |
| FY 2002 | $-255.9k | 2002-01-04 – 2002-12-31 | evidence 0001193125-12-143728 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CATALYST PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income